Glenmark Pharmaceuticals Inc., USA will introduce Ropivacaine Hydrochloride Injection USP in three concentrations: 2mg/mL, 5mg/mL, and 10mg/mL, available in 20mL and 30mL single-dose vials.

by | Oct 25, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Ropivacaine Hydrochloride Injection USP, a generic version of Naropin Injection, in November 2025. The new product will be available in three strengths: 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5...
China’s NMPA grants approval to products from Zydus and Glenmark.

Several Indian pharmaceutical companies, including Glenmark, Granules, and Zydus, have issued recalls for certain medications in the US market due to concerns over quality, as reported by the US Food and Drug Administration (USFDA).

by | Sep 28, 2025 | Glenmark, Pharma, Sun Pharma, Zydus

Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, as reported by the US Food and Drug Administration (USFDA). The recalls are related to manufacturing problems, impurities, and labeling errors. Glenmark...
China’s NMPA grants approval to products from Zydus and Glenmark.

Several pharmaceutical companies, including Zydus, Sun Pharma, and Glenmark, have issued recalls of their medications in the US due to concerns regarding quality standards.

by | Sep 28, 2025 | Glenmark, Pharma, Sun Pharma, Zydus

Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, including manufacturing problems, impurities, and labeling errors, as reported by the US Food and Drug Administration (USFDA). The recalls affect a range of...